Literature DB >> 21170826

Impact of land-based neonatal transport on outcomes in transient tachypnea of the newborn.

Belma Saygili Karagol1, Aysegul Zenciroglu, Mehmet Sah Ipek, Ahmet Afsin Kundak, Nurullah Okumus.   

Abstract

We sought to determine the effect of neonatal transport on the incidence of adverse events of transient tachypnea of the newborn (TTN) in term neonates. A retrospective study was performed of neonates who had TTN and were admitted to Neonatal Intensive Care Unit (NICU) of Sami Ulus Maternity, Children's Education and Research Hospital by land-based transport. Data from 208 newborns with TTN were evaluated, and clinical and laboratory findings were compared between patients who were transported from within the city (group 1) or from outside of the city (group 2). In the present study, long-distance land-based neonatal transport increased the adverse effects of TTN in newborns. Arterial blood gas parameters of the neonates in both groups before transport were similar, and these parameters and Downes' scores were comparable in both groups, implying that patients from outside the city had greater respiratory insufficiency than those from inside the city at admission to NICU. Respiratory support in the NICU and pulmonary air leak syndrome ratios were found to be significantly higher in the group from outside the city. Long-distance land-based transport in neonates with TTN increases the severity of illness. Furthermore, adverse events and the outcome of such infants depend on the effectiveness of the neonatal transport system. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21170826     DOI: 10.1055/s-0030-1270115

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  1 in total

1.  A nationwide survey on neonatal medical resources in mainland China: current status and future challenges.

Authors:  Qiuping Li; Tao Han; Yanping Zhang; Qian Zhang; Xiangyong Kong; Yonghui Yang; Zhichun Feng
Journal:  BMC Pediatr       Date:  2019-11-13       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.